Rochelle Stenzler, B.Sc.Phm., ICD.D
Chair of the Board of Directors; Former Board Chair, Cynapsus Therapeutics; Former President Touchlogic, TLC, Revlon Canada, Pharma Plus Drugmarts; Former Vice Chair, Humber River Hospital
Rochelle Stenzler has a distinguished business career as both a board director and senior executive, including serving as the Chair of the Board of Cynapsus Therapeutics (NASDAQ: CYNA), until it was acquired for C$841M by Sunovion Pharmaceuticals. She currently serves as an Advisory Board member of Social Capital Partners.
She has extensive experience as a senior executive in healthcare, retailing, consumer packaged goods, and IVR technology. Rochelle's executive leadership roles include being President & CEO of TouchLogic Corporation; President, International Operations of TLC Laser Eye Centers Inc.; President of Revlon Canada Inc.; and President & General Manager of Pharma Plus Drugmarts Ltd.
Rochelle is originally a pharmacist by education and training. She is a graduate of the University of Toronto with a Bachelor of Science in Pharmacy and a Gold Medal in Compounding and Dispensing, and the Rotman School of Management, Institute of Corporate Directors, with an ICD.D.